Hem/Onc Library - Page 9 of 52 - SOHO Insider

Skip to content

SOHO announces exclusive MDS, AML session on September 8 in Houston; register now
Dr. Raheel Iftikhar weighs in on AI in blood cancers
Atezolizumab plus obinutuzumab, radiotherapy combination safe, effective against FL
Dr. Feng-Ming Tien on immune landscapes and the future of AML risk stratification
Don’t miss SOHO 2026 poster walks

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Cellular Therapy

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Leukemia

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Lymphoma

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Multiple Myeloma

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Myelodysplastic Syndromes

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

April 13, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library

ASH 2025 Cellular Therapy Leukemia Acute Myeloid Leukemia

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

by Leah Sherwood
January 9, 2026
0 Comments

ASH 2025 Cellular Therapy Multiple Myeloma News

Earlier lines of cilta-cel linked to better immune fitness in myeloma

by Leah Sherwood
January 8, 2026
0 Comments

Jason Westin, MD

Lymphoma Roundtable ASH 2025 Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Roundtable Discussions Video Interviews

What are the therapeutic combinations in large cell lymphoma?

by SOHO Insider Editors
January 6, 2026
0 Comments

Belinda Avalos at ASH 2025

ASH 2025 Cellular Therapy Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas

Dr. Avalos highlights ASH 2025 takeaways, the future of blood cancer

by Leah Sherwood
January 5, 2026
0 Comments

Pan Yu Chen

ASH 2025 Myeloma

Novel protein degraders target myeloma

by SOHO Insider Editors
January 5, 2026
0 Comments

Loretta Nastoupil

Lymphoma Roundtable ASH 2025 Lymphoma Indolent B-Cell Lymphomas Roundtable Discussions Video Interviews

What is the 2025 treatment landscape of follicular lymphoma?

by SOHO Insider Editors
January 2, 2026
0 Comments

Sagar Lonial

SOHO 2026 Multiple Myeloma News Society Updates

Facing 2026 with a mix of inspiration and trepidation

by SOHO Insider Editors
January 2, 2026
0 Comments

Phase 1 PROMISE Trial Updates

Trending now ASH 2025 Myeloproliferative Neoplasms Primary Myelofibrosis

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

by SOHO Insider Editors
December 31, 2025
0 Comments

Pearl Van Heteren

ASH 2025 Lymphoma Aggressive B-Cell Lymphomas

Pearl van Heteren, MD, on the DALY 2-EU trial in R/R DLBCL

by SOHO Insider Editors
December 30, 2025
0 Comments

Dr. Swetha Thiruvengdam

Lymphoma Roundtable Lymphoma Indolent B-Cell Lymphomas Roundtable Discussions Video Interviews

How do you approach frontline patients in follicular lymphoma?

by SOHO Insider Editors
December 26, 2025
0 Comments

Load More

Top Categories

Cellular Therapy

65

Leukemia

102

Lymphoma

111

Multiple Myeloma

87

Myelodysplastic Syndromes

34

Myeloproliferative Neoplasms

21

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

How do you approach frontline patients in follicular lymphoma?

Cellular Therapy

How do you approach frontline patients in follicular lymphoma?

Leukemia

How do you approach frontline patients in follicular lymphoma?

Lymphoma

How do you approach frontline patients in follicular lymphoma?

Multiple Myeloma

How do you approach frontline patients in follicular lymphoma?

Myelodysplastic Syndromes

How do you approach frontline patients in follicular lymphoma?

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Exclusive_Session_SOHO_26

SOHO announces exclusive MDS, AML session on September 8 in Houston; register now

Microscope in AI virtual pattern

Dr. Raheel Iftikhar weighs in on AI in blood cancers

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Atezolizumab plus obinutuzumab, radiotherapy combination safe, effective against FL

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.